Endocrine, reproductive, and cardiovascular drugs
Endocrine, Reproductive, and Cardiovascular Drugs
Complete the aftercited and acquiesce your answers.
· Chapter 23, page 470, Case Study B- Antidiabetic Agents and page 471, questions 1 through 10.
· Chapter 25, page 494, questions 1 through 10.
Chapter 23, page 470, Case Study B – Antidiabetic Drugs
1. The physician starts him on glyburide, a sulfonylurea medication. He explains to Marcus that sulfonylureas composition by:
2. The physician explains to Marcus that one of the laterality property of a sulfonylurea medication is:
3. Prior to prescribing the medication, the physician reviews Marcus’s medical narrative. This is consequently sulfonylureas must be used after a while distant inadventurousness in individual’s who:
4. The physician inadventurousnesss Marcus to ole him previous to induction any other medication consequently of likely interactions. Which garbage can potentiate the hypoglycemic issue of a sulfonylurea?
5. What garbage causes an interforce after a while sulfonylureas, resulting in adverse force in which a larger dose may be required?
Antidiabetic Agents and page 471, questions 1 through 10.
1. Glucophage – Oral antidiabetic agent
2. prednisone - Corticosteroid
3. Humulin R - Insulin: insufficient acting
4. Synthroid – Thyroid agent
5. Avandia - Oral antidiabetic agent
6. Tapazole – Antithyroid
7. Isophane - Insulin: interjacent acting
8. Prandin - Oral antidiabetic agent
9. Lantus – Insulin: desire acting
10. Humalog – Insulin: flying acting
Chapter 25, page 494 (in-fact pg. 541), questions 1 through 10
1. isosorbide - Angina
2. Zetia – Elevated cholesterol
3. Lovenox – Pulmonary emboli
4. Cardizem – Hypertension
5. Zocor – Elevated cholesterol
6. Plavix – Stroke stoppage (platelet inhibitor)
7. Crestor – Elevated cholesterol
8. hydralazine – Hypertension
9. quinidine – Cardiac arrhythmia
10. procainamide - Cardiac arrhythmia